Editorial: Molecular Mechanisms in Cancer Endocrinology With Clinical Implications

por Nilubol, Naris
Publicado 2022

Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome

por Boufraqech, Myriem, Nilubol, Naris
Publicado 2019

Current Status and Future Targeted Therapy in Adrenocortical Cancer

por Alyateem, George, Nilubol, Naris
Publicado 2021

Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer

por Michael, Nicholas, Nilubol, Naris
Publicado 2022

New Therapies for Advanced Thyroid Cancer

por Laha, Diprajan, Nilubol, Naris, Boufraqech, Myriem
Publicado 2020

Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure

por Libutti, Steven K., Tamarkin, Lawrence, Nilubol, Naris
Publicado 2018

The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment

por Laha, Dipranjan, Grant, Robert, Mishra, Prachi, Nilubol, Naris
Publicado 2021

Advances in Biomarker-Driven Targeted Therapies in Thyroid Cancer

por Mishra, Prachi, Laha, Dipranjan, Grant, Robert, Nilubol, Naris
Publicado 2021

Is VTE Prophylaxis Necessary on Discharge for Patients Undergoing Adrenalectomy for Cushing Syndrome?

por Babic, Bruna, De Roulet, Amory, Volpe, Anita, Nilubol, Naris
Publicado 2018

SAT-568 Glutamine Metabolism Is a New Potential Therapeutic Target in Aggressive Thyroid Cancer

por Patel, Dhaval, King, Timothy, Kebebew, Electron, Nilubol, Naris, Boufraqech, Myriem
Publicado 2019

SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma

por Tirosh, Amit, Boufraqech, Myriem, Nilubol, Naris, Kebebew, Electron, Patel, Dhaval
Publicado 2019

RF07 | PSUN356 Synergistic Combination of HSP90 and PI3K inhibitors in Adrenocortical Cancer

por Mishra, Prachi, Shen, Min, Hall, Matthew, Zhang, Ya-Qin, Nilubol, Naris
Publicado 2022

Adrenocortical carcinoma and pulmonary embolism from tumoral extension

por Shekhar, Skand, Gubbi, Sriram, Papadakis, Georgios Z, Nilubol, Naris, Hannah-Shmouni, Fady
Publicado 2019

SAT163 Title: Adult-onset Hyperinsulinemic Hypoglycemia Due To An Activating Mutation In Glucokinase

por Vaid, Sonal, Ghosh, Raisa, Elenius, Henrik, Cochran, Craig, Chang, Richard, Nilubol, Naris, Muniyappa, Ranganath
Publicado 2023

Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening

por Nilubol, Naris, Zhang, Lisa, Shen, Min, Zhang, Ya-Qin, He, Mei, Austin, Christopher P, Kebebew, Electron
Publicado 2012

Postoperative Management in Patients with Pheochromocytoma and Paraganglioma

por Mamilla, Divya, Araque, Katherine A., Brofferio, Alessandra, Gonzales, Melissa K., Sullivan, James N., Nilubol, Naris, Pacak, Karel
Publicado 2019

LBSAT144 Single-center Experience With Hyperparathyroidism-jaw Tumor Syndrome - Where Do We Stand?

por Tora, Rana S, Welch, James M, Vikram, Nayan U, Nilubol, Naris, Agrawal, Sunita K, Weinstein, Lee S, Simonds, William F, Jha, Smita
Publicado 2022

Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response

por Nilubol, Naris, Boufraqech, Myriem, Zhang, Lisa, Gaskins, Kelli, Shen, Min, Zhang, Ya-Qin, Gara, Sudheer K., Austin, Christopher P., Kebebew, Electron
Publicado 2018

LBSAT145 Localizing The "Difficult" Parathyroid Tumor

por Graf, Akua, Cochran, Craig, Abijo, Tomilowo, Sadowski, Samira Mercedes, Nilubol, Naris, Simonds, William F, Weinstein, Lee Scott, Chang, Richard, Jha, Smita
Publicado 2022

Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas w...

por Neychev, Vladimir, Steinberg, Seth M, Cottle-Delisle, Candice, Merkel, Roxanne, Nilubol, Naris, Yao, Jianhua, Meltzer, Paul, Pacak, Karel, Marx, Stephen, Kebebew, Electron
Publicado 2015